Arkadios Wealth Advisors Has $703,000 Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Arkadios Wealth Advisors decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 46.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 9,362 shares of the company’s stock after selling 8,246 shares during the quarter. Arkadios Wealth Advisors’ holdings in GE HealthCare Technologies were worth $703,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in GEHC. Allstate Corp bought a new stake in GE HealthCare Technologies during the third quarter worth about $1,226,000. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of GE HealthCare Technologies by 13.4% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 59,212 shares of the company’s stock worth $4,411,000 after acquiring an additional 6,986 shares in the last quarter. Inspire Advisors LLC bought a new stake in GE HealthCare Technologies during the 3rd quarter worth approximately $556,000. Rovin Capital UT ADV increased its holdings in GE HealthCare Technologies by 5.4% during the 3rd quarter. Rovin Capital UT ADV now owns 7,165 shares of the company’s stock valued at $538,000 after purchasing an additional 366 shares in the last quarter. Finally, Florida Trust Wealth Management Co increased its holdings in GE HealthCare Technologies by 3.6% during the 3rd quarter. Florida Trust Wealth Management Co now owns 7,515 shares of the company’s stock valued at $564,000 after purchasing an additional 260 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Barclays assumed coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective on the stock. Morgan Stanley upped their price target on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 30th. BTIG Research restated a “buy” rating and issued a $87.00 price objective on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Citigroup boosted their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $89.83.

GE HealthCare Technologies Trading Down 2.6%

GEHC opened at $79.77 on Monday. The firm has a 50 day simple moving average of $81.98 and a 200 day simple moving average of $77.23. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a market cap of $36.34 billion, a price-to-earnings ratio of 16.48, a price-to-earnings-growth ratio of 2.41 and a beta of 1.08. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the firm earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.